Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$2.82 - $7.94 $5,975 - $16,824
2,119 New
2,119 $14,000
Q4 2022

Feb 02, 2023

BUY
$5.44 - $9.46 $359 - $624
66 New
66 $0
Q2 2022

Aug 03, 2022

SELL
$8.48 - $16.84 $356 - $707
-42 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$8.87 - $22.1 $48,838 - $121,682
-5,506 Reduced 99.24%
42 $0
Q4 2021

Feb 23, 2022

BUY
$10.79 - $22.87 $59,862 - $126,882
5,548 New
5,548 $126,000

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $336M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.